What We Know About Type 2 Diabetes and Heart Health in Older Adults

A large study from Hong Kong examined whether a common cholesterol medication helps prevent heart disease in older people with type 2 diabetes. Here's what the research shows.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

causesautoimmunitygeneticsrisk

Key takeaways

This study looked at real medical records from thousands of older adults with type 2 diabetes to understand how statin therapy affects heart disease prevention
The research included people aged 60 and older, with a focus on those 75 and older—a group that hasn't been well-studied in previous trials
The study compared outcomes for people who started statin therapy with those who didn't, following them over several years
This type of research helps fill gaps in our understanding of heart disease prevention strategies for aging populations with type 2 diabetes

Why This Research Matters

People with type 2 diabetes face higher risks for heart disease and stroke. Statins are medications commonly prescribed to help lower cholesterol and reduce these risks. However, most earlier studies of statin therapy were conducted in younger adults, leaving uncertainty about how well these medications work in older people—especially those aged 75 and beyond.

This new research from Hong Kong aimed to fill that gap by examining real-world medical records from thousands of older adults with type 2 diabetes who either started taking statins or did not.

How the Study Was Designed

Researchers used electronic health records from hospitals in Hong Kong spanning from 2009 to 2015. They looked at adults aged 60 and older who had type 2 diabetes and elevated LDL cholesterol (the 'bad' cholesterol). They then compared outcomes for people who started statin therapy with those who didn't.

To ensure their findings were reliable, researchers broke down results by age group: 60–74 years old (used as a comparison group), 75–84 years old, and 85 years and older. This approach allowed them to see whether statin therapy worked differently across age groups.

What This Means for Type 1 Diabetes Community

While this study focused on type 2 diabetes, the research contributes important knowledge about cardiovascular health and aging that may have broader implications. Understanding heart disease prevention strategies across different ages and populations helps the entire diabetes community.

Type 1 Cure is committed to translating research into clear, accessible information. As scientists continue studying ways to protect heart health in people with diabetes of all types, studies like this one expand our collective understanding of what works and what remains unknown.

Evidence label

Source: PLoS medicine. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.